The Fas Counterattack: A Molecular Mechanism of Tumor Immune Privilege

被引:0
|
作者
Joe O’Connell
Michael W. Bennett
Gerald C. O’Sullivan
J. Kevin Collins
Fergus Shanahan
机构
[1] National University of Ireland,Department of Medicine
[2] National University of Ireland,Department of Surgery
[3] University Hospital,Department of Medicine, Clinical Sciences Building
来源
Molecular Medicine | 1997年 / 3卷
关键词
Tumor Immune Privilege; FasL Expression; Hematopoietic Cell Protein-tyrosine Phosphatase (HCP); Monocytic Leukemia Cell Line U937; Diverse Cancer Cell Lines;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:294 / 300
页数:6
相关论文
共 50 条
  • [21] The role of Fas ligand in immune privilege
    Douglas R. Green
    Thomas A. Ferguson
    Nature Reviews Molecular Cell Biology, 2001, 2 : 917 - 924
  • [22] The role of Fas ligand in immune privilege
    Green, DR
    Ferguson, TA
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) : 917 - 924
  • [23] Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
    Nicholas P. Restifo
    Nature Medicine, 2000, 6 : 493 - 495
  • [24] Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
    O'Connell, J
    Bennett, MW
    O'Sullivan, GC
    Roche, D
    Kelly, J
    Collins, JK
    Shanahan, F
    JOURNAL OF PATHOLOGY, 1998, 186 (03): : 240 - 246
  • [25] Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
    Restifo, NP
    NATURE MEDICINE, 2000, 6 (05) : 493 - 495
  • [26] Expression of FasL in Proliferation of Retinoblastoma Cells: A Mechanism Fas Counterattack
    Soebagjo, Hendrian D.
    Sujuti, Hidayat
    Machfoed, Hasan
    Soemitro, Sutiman Bambang
    CUKUROVA MEDICAL JOURNAL, 2014, 39 (04): : 788 - 794
  • [27] The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability
    Houston, Aileen M.
    Michael-Robinson, Julie M.
    Walsh, Michael D.
    Cummings, Margaret C.
    Ryan, Aideen E.
    Lincoln, Douglas
    Pandeya, Nirmala
    Jass, Jeremy R.
    Radford-Smith, Graham L.
    O'Connell, Joe
    HUMAN PATHOLOGY, 2008, 39 (02) : 243 - 250
  • [28] Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion
    Uckan, D
    Steele, A
    Cherry
    Wang, BY
    Chamizo, W
    Koutsonikolis, A
    GilbertBarness, E
    Good, RA
    MOLECULAR HUMAN REPRODUCTION, 1997, 3 (08) : 655 - 662
  • [29] Evidence for immune evasion by the 'Fas counterattack' in vivo in esophageal cancer.
    Bennett, MW
    O'Connell, J
    O'Sullivan, GC
    Collins, JK
    Shanahan, F
    GASTROENTEROLOGY, 1998, 114 (04) : A565 - A565
  • [30] Fas/Fas-ligand interactions modulate immune privilege and immune deviation in the eye.
    Ferguson, TA
    Herndon, JM
    Griffith, TS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 5202 - 5202